Amedisys Price to Sales Ratio 2010-2024 | AMED

Historical PS ratio values for Amedisys (AMED) over the last 10 years. The current P/S ratio for Amedisys as of November 07, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Amedisys P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-11-06 97.71 1.40
2024-06-30 91.80 $69.67 1.32
2024-03-31 92.16 $68.75 1.34
2023-12-31 95.06 $68.47 1.39
2023-09-30 93.40 $68.17 1.37
2023-06-30 91.44 $68.34 1.34
2023-03-31 73.55 $68.44 1.07
2022-12-31 83.54 $68.03 1.23
2022-09-30 96.79 $67.78 1.43
2022-06-30 105.12 $67.50 1.56
2022-03-31 172.29 $67.67 2.55
2021-12-31 161.88 $67.48 2.40
2021-09-30 149.10 $67.27 2.22
2021-06-30 244.93 $66.95 3.66
2021-03-31 264.79 $64.96 4.08
2020-12-31 293.33 $63.31 4.63
2020-09-30 236.43 $61.73 3.83
2020-06-30 198.54 $60.22 3.30
2020-03-31 183.54 $59.93 3.06
2019-12-31 166.92 $59.34 2.81
2019-09-30 131.01 $57.09 2.29
2019-06-30 121.41 $54.87 2.21
2019-03-31 123.26 $51.44 2.40
2018-12-31 117.11 $48.83 2.40
2018-09-30 124.96 $46.78 2.67
2018-03-31 60.34 $44.94 1.34
2017-12-31 52.71 $44.10 1.20
2017-09-30 55.96 $42.82 1.31
2017-06-30 62.81 $43.98 1.43
2017-03-31 51.09 $43.75 1.17
2016-12-31 42.63 $43.75 0.97
2018-06-30 85.46 $43.85 1.95
2016-09-30 47.44 $42.05 1.13
2016-06-30 50.48 $41.07 1.23
2016-03-31 48.34 $39.75 1.22
2015-12-31 39.32 $38.56 1.02
2015-09-30 37.97 $37.46 1.01
2015-06-30 39.73 $36.87 1.08
2015-03-31 26.78 $36.84 0.73
2014-12-31 29.35 $37.01 0.79
2014-09-30 20.17 $37.56 0.54
2014-06-30 16.74 $38.01 0.44
2014-03-31 14.89 $38.69 0.38
2013-12-31 14.63 $39.87 0.37
2013-09-30 17.21 $41.62 0.41
2013-06-30 11.60 $44.03 0.26
2013-03-31 11.12 $46.09 0.24
2012-12-31 11.31 $47.98 0.24
2012-09-30 13.82 $47.69 0.29
2012-06-30 12.45 $48.58 0.26
2012-03-31 14.46 $49.19 0.29
2011-12-31 10.91 $49.41 0.22
2011-09-30 14.82 $52.45 0.28
2011-06-30 26.63 $54.35 0.49
2010-12-31 33.50 $56.21 0.60
2010-09-30 23.80 $57.09 0.42
2010-06-30 43.98 $55.34 0.79
2010-03-31 55.22 $54.48 1.01
2009-12-31 48.60 $53.64 0.91
2011-03-31 35.00 $52.60 0.67
2009-09-30 43.63 $57.89 0.75
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.169B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.553B 12.43
Quest Diagnostics (DGX) United States $17.434B 17.67
DaVita (DVA) United States $12.330B 15.95
Encompass Health (EHC) United States $10.431B 24.59
Chemed (CHE) United States $8.349B 25.66
Elanco Animal Health (ELAN) United States $7.168B 17.06
RadNet (RDNT) United States $5.281B 125.26
Option Care Health (OPCH) United States $3.902B 18.49
LifeStance Health (LFST) United States $2.939B 0.00
Astrana Health (ASTH) United States $2.900B 45.45
Addus HomeCare (ADUS) United States $2.341B 27.46
U.S Physical Therapy (USPH) United States $1.436B 37.81
Pennant (PNTG) United States $1.099B 44.44
Aveanna Healthcare Holdings (AVAH) United States $1.080B 0.00
Atai Life Sciences (ATAI) Germany $0.227B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00